Highlights and News
- New data reveals ethnic disparities in early rheumatoid arthritis treatment - University of Birmingham
- New data reveals ethnic disparities in early rheumatoid arthritis treatment University of Birmingham
- Factors associated with biological and targeted synthetic disease-modifying antirheumatic drug initiation for rheumatoid arthritis in underserved patient groups in England and Wales, UK: a national cohort study - The Lancet
- Factors associated with biological and targeted synthetic disease-modifying antirheumatic drug initiation for rheumatoid arthritis in underserved patient groups in England and Wales, UK: a national cohort study The Lancet
- Rheumatoid Arthritis Life Expectancy: What You Need to Know - HealthCentral
- Rheumatoid Arthritis Life Expectancy: What You Need to Know HealthCentral
- Molecular Portraits of Early Rheumatoid Arthritis Identify Clinical and Treatment Response Phenotypes - ScienceDirect.com
- Molecular Portraits of Early Rheumatoid Arthritis Identify Clinical and Treatment Response Phenotypes ScienceDirect.com
- Nurse-led care for people with early rheumatoid arthritis: Interview study with thematic analysis - Wiley Online Library
- Nurse-led care for people with early rheumatoid arthritis: Interview study with thematic analysis Wiley Online Library
- Clinical Trials and Resources - Arthritis Foundation
- Clinical Trials and Resources Arthritis Foundation
- Impact of Rheumatoid Arthritis and Its Management on Falls, Fracture and Bone Mineral Density in UK Biobank - Frontiers
- Impact of Rheumatoid Arthritis and Its Management on Falls, Fracture and Bone Mineral Density in UK Biobank Frontiers
- Rheumatoid Arthritis: Autoimmune Joint Inflammation - HSS | Hospital for Special Surgery
- Rheumatoid Arthritis: Autoimmune Joint Inflammation HSS | Hospital for Special Surgery
- 11 Signs Your Rheumatoid Arthritis May Be Getting Worse, and You Should See a Doctor - CreakyJoints
- 11 Signs Your Rheumatoid Arthritis May Be Getting Worse, and You Should See a Doctor CreakyJoints
- RA-MAP, molecular immunological landscapes in early rheumatoid arthritis and healthy vaccine recipients - Nature
- RA-MAP, molecular immunological landscapes in early rheumatoid arthritis and healthy vaccine recipients Nature
- Rheumatoid arthritis: features, causes and diagnosis - The Pharmaceutical Journal
- Rheumatoid arthritis: features, causes and diagnosis The Pharmaceutical Journal
- Arthritis drug effective in treating sickest COVID-19 patients - Imperial College London
- Arthritis drug effective in treating sickest COVID-19 patients Imperial College London
- Osteoarthritis - World Health Organization (WHO)
- Osteoarthritis World Health Organization (WHO)
- Rheumatoid arthritis and socioeconomic status: a need to address SES in the UK - Clinical Trials Arena
- Rheumatoid arthritis and socioeconomic status: a need to address SES in the UK Clinical Trials Arena
- Approaches to optimising access to NICE-approved biologic anti-TNFs for patients with rheumatoid arthritis with moderately active disease - BMC Medicine
- Approaches to optimising access to NICE-approved biologic anti-TNFs for patients with rheumatoid arthritis with moderately active disease BMC Medicine
- Rheumatoid arthritis - The Lancet
- Rheumatoid arthritis The Lancet
- The 4 Stages of Rheumatoid Arthritis Progression - CreakyJoints
- The 4 Stages of Rheumatoid Arthritis Progression CreakyJoints
- Abatacept in individuals at high risk of rheumatoid arthritis (APIPPRA): a randomised, double-blind, multicentre, parallel, placebo-controlled, phase 2b clinical trial - The Lancet
- Abatacept in individuals at high risk of rheumatoid arthritis (APIPPRA): a randomised, double-blind, multicentre, parallel, placebo-controlled, phase 2b clinical trial The Lancet
- Stratification of biological therapies by pathobiology in biologic-naive patients with rheumatoid arthritis (STRAP and STRAP-EU): two parallel, open-label, biopsy-driven, randomised trials - The Lancet
- Stratification of biological therapies by pathobiology in biologic-naive patients with rheumatoid arthritis (STRAP and STRAP-EU): two parallel, open-label, biopsy-driven, randomised trials The Lancet
- Towards stratified treatment of JIA: machine learning identifies subtypes in response to methotrexate from four UK cohorts - The Lancet
- Towards stratified treatment of JIA: machine learning identifies subtypes in response to methotrexate from four UK cohorts The Lancet
- Asian and older rheumatoid arthritis sufferers 50% less likely to receive targeted treatment, finds study - Medical Xpress
- Asian and older rheumatoid arthritis sufferers 50% less likely to receive targeted treatment, finds study Medical Xpress
- Rheumatology - Northumbria Healthcare NHS Foundation Trust
- Rheumatology Northumbria Healthcare NHS Foundation Trust
- Rheumatoid arthritis diagnosis and management: a clinical update - nursingtimes.net
- Rheumatoid arthritis diagnosis and management: a clinical update nursingtimes.net
- Signaling pathways in rheumatoid arthritis: implications for targeted therapy | Signal Transduction and Targeted Therapy - Nature
- Signaling pathways in rheumatoid arthritis: implications for targeted therapy | Signal Transduction and Targeted Therapy Nature
- The Role of Ultrasound Across the Inflammatory Arthritis Continuum: Focus on "At-Risk” Individuals - Frontiers
- The Role of Ultrasound Across the Inflammatory Arthritis Continuum: Focus on "At-Risk” Individuals Frontiers
- The N-Formyl Peptide Receptors and Rheumatoid Arthritis: A Dangerous Liaison or Confusing Relationship? - Frontiers
- The N-Formyl Peptide Receptors and Rheumatoid Arthritis: A Dangerous Liaison or Confusing Relationship? Frontiers
- Risk stratified monitoring for methotrexate toxicity in immune mediated inflammatory diseases: prognostic model development and validation using primary care data from the UK - The BMJ
- Risk stratified monitoring for methotrexate toxicity in immune mediated inflammatory diseases: prognostic model development and validation using primary care data from the UK The BMJ
- Deconstruction of rheumatoid arthritis synovium defines inflammatory subtypes - Nature
- Deconstruction of rheumatoid arthritis synovium defines inflammatory subtypes Nature
- Adalimumab is found to be a cost-effective treatment for early-stage Dupuytren's disease - ndph.ox.ac.uk
- Adalimumab is found to be a cost-effective treatment for early-stage Dupuytren's disease ndph.ox.ac.uk
- Early Menopause, Hormone Replacement Therapy May Raise Rheumatoid Arthritis Risk - Healthline
- Early Menopause, Hormone Replacement Therapy May Raise Rheumatoid Arthritis Risk Healthline
- Rheumatoid Arthritis & Jaw Pain: Here's How to Deal - HealthCentral
- Rheumatoid Arthritis & Jaw Pain: Here's How to Deal HealthCentral
- Factors associated with resolution of ultrasound subclinical synovitis in anti-CCP-positive individuals with musculoskeletal symptoms: a UK prospective cohort study - The Lancet
- Factors associated with resolution of ultrasound subclinical synovitis in anti-CCP-positive individuals with musculoskeletal symptoms: a UK prospective cohort study The Lancet
- Cholesterol Levels and Rheumatoid Arthritis: What's the Link? - HealthCentral
- Cholesterol Levels and Rheumatoid Arthritis: What's the Link? HealthCentral
- Rheumatoid arthritis - Nature
- Rheumatoid arthritis Nature
- Rheumatoid Arthritis X-Ray: Diagnosis and Evaluation - HealthCentral
- Rheumatoid Arthritis X-Ray: Diagnosis and Evaluation HealthCentral
- Single-cell insights into immune dysregulation in rheumatoid arthritis flare versus drug-free remission - Nature
- Single-cell insights into immune dysregulation in rheumatoid arthritis flare versus drug-free remission Nature
- Transcriptomic profiling of programmed cell death 1 (PD-1) expressing T cells in early rheumatoid arthritis identifies a decreased CD4 + PD-1 + signature post-treatment - Nature
- Transcriptomic profiling of programmed cell death 1 (PD-1) expressing T cells in early rheumatoid arthritis identifies a decreased CD4 + PD-1 + signature post-treatment Nature
- Biological disease‐modifying drugs for rheumatoid arthritis - Chaplin - 2020 - Prescriber - Wiley Online Library
- Biological disease‐modifying drugs for rheumatoid arthritis - Chaplin - 2020 - Prescriber Wiley Online Library
- Blocking the immune system in rheumatoid arthritis - The Pharmaceutical Journal
- Blocking the immune system in rheumatoid arthritis The Pharmaceutical Journal
- 6 Common Questions About Taking Prednisone for Rheumatoid Arthritis - CreakyJoints
- 6 Common Questions About Taking Prednisone for Rheumatoid Arthritis CreakyJoints
- Palliative care - World Health Organization (WHO)
- Palliative care World Health Organization (WHO)
- 8 Signs of Arthritis You Shouldn't Ignore - AARP
- 8 Signs of Arthritis You Shouldn't Ignore AARP
- Prediction of response of methotrexate in patients with rheumatoid arthritis using serum lipidomics - Nature
- Prediction of response of methotrexate in patients with rheumatoid arthritis using serum lipidomics Nature
- Identification of novel urinary biomarkers for assessing disease activity and prognosis of rheumatoid arthritis - Nature
- Identification of novel urinary biomarkers for assessing disease activity and prognosis of rheumatoid arthritis Nature
- Cancer Q&A: Our health experts answer your questions on early signs, testing, treatments and more - The Telegraph
- Cancer Q&A: Our health experts answer your questions on early signs, testing, treatments and more The Telegraph
- Rheumatoid arthritis: How to spot arthritis bumps - location and size - Daily Express
- Rheumatoid arthritis: How to spot arthritis bumps - location and size Daily Express
- Rheumatoid arthritis: management - The Pharmaceutical Journal
- Rheumatoid arthritis: management The Pharmaceutical Journal
- 10 Natural remedies for rheumatoid arthritis - Medical News Today
- 10 Natural remedies for rheumatoid arthritis Medical News Today
- CAR T-cell therapy may be a ‘miracle,' but it is too soon to say ‘cure' - Healio
- CAR T-cell therapy may be a ‘miracle,' but it is too soon to say ‘cure' Healio
- Rheumatoid arthritis: Overweight and obese people at greater risk - Daily Express
- Rheumatoid arthritis: Overweight and obese people at greater risk Daily Express
- Osteoarthritis in primary care: early diagnosis and management - GPonline
- Osteoarthritis in primary care: early diagnosis and management GPonline
- Early Treatment Improves Rheumatoid Arthritis Symptoms, Helps Patients Live Longer, Study Suggests - rheumatoidarthritisnews.com
- Early Treatment Improves Rheumatoid Arthritis Symptoms, Helps Patients Live Longer, Study Suggests rheumatoidarthritisnews.com
- Infliximab and Methotrexate in the Treatment of Rheumatoid Arthritis - The New England Journal of Medicine
- Infliximab and Methotrexate in the Treatment of Rheumatoid Arthritis The New England Journal of Medicine
- Infliximab and Methotrexate in the Treatment of Rheumatoid Arthritis - The New England Journal of Medicine
- Infliximab and Methotrexate in the Treatment of Rheumatoid Arthritis The New England Journal of Medicine
Articles/peer reviewed publications and
Lay Summaries
-
B cell synovitis and clinical phenotypes in rheumatoid arthritis: relationship to disease stages and drug exposure.
Rivellese F, Humby F, Bugatti S, Fossati-Jimack L, Rizvi H, Lucchesi D, Lliso-Ribera G, Nerviani A, Hands RE, Giorli G, Frias B, Thorborn G, Jaworska E, John C, Goldmann K, Lewis MJ, Manzo A, Bombardieri M, Pitzalis C; PEAC- R4RA investigators.
Arthritis Rheumatol. 2019 Nov 29.
https://doi.org/10.1002/art.41184
See Lay Summary
